Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Acrotech, Astellas, Astrazeneca, Biontech, Bristol Myers Squibb, CASI, Duality, Fuji, Grünenthal, Hefei Tianhui, Kyowa Kirin, Mithra, Mthera, Mundipharma, Neurobo, Ono, Oramed, Poseida, Recce.